Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection

Journal of Immunotherapy

Volumn 25, Issue 6, 2002, Pages 445-454

  Lundqvist, Andreas ^a   Noffz, Gabriele ^a   Pavlenko, Maxim ^a   Sæbøe Larssen, Stein ^a   Fong, Timothy ^a   Maitland, Norman ^a   Pisa, Pavel ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dendritic cells; Electroporation; Gene transfer; Transfection efficiency

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; PLASMID DNA; RETROVIRUS VECTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENE; VIRAL GENE THERAPY;

ADENOVIRIDAE; BIOLISTICS; CELL DIFFERENTIATION; CELLS, CULTURED; DEFECTIVE VIRUSES; DENDRITIC CELLS; DNA, RECOMBINANT; ELECTROPORATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; LIPOSOMES; LUMINESCENT PROTEINS; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; PLASMIDS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 0036844382     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200211000-00001     Document Type: Article

References (52)

1. Banchereau J. Dendritic cells: Therapeutic potentials. Transfus Sci 1997;18:313-26.
2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
3. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
4. Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol 1996;24:859-62.
5. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000;18:245-73.
6. Gilboa E. Immunotherapy of cancer with DC-based vaccines. Cancer Immunol Immunother 1998;46:82-7.
7. + cells. Cryobiology 1998; 37:362-71.
8. Thurner B, Roder C, Dieckmann D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999;223:1-15.
9. Timares L. Quantitative analysis of the immunopotency of genetically transfected DC. PNAS 1998;95:13147-52.
10. Holtl L, Rieser C, Papesh C, et al. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 1999;161:777-82.
11. Hsu FJ, Benike C. Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8.
12. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med 1995;1:1297-302.
13. Nestle FO. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed DC. Nat Med 1998;4:328-32.
14. Paglia P, Chiodoni C, Rodolfo M, et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996;183:317-22.
15. Ashley DM, Faiola B, Nair S, et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997;186:1177-82.
16. Boczkowski D, Nair SK, Nam JH, et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 2000;60:1028-34.
17. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A 1998;95:9482-7.
18. Gong J, Chen L, Chen D, et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 1997;4:1023-8.
19. Specht JM, Wang G, Do MT, et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997;186: 1213-21.
20. Song W, Kong HL, Carpenter H, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997;186:1247-56.
21. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
22. Sæbøe-Larssen S, Fossberg E, Gaudernack G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 2001;259:193-204.
23. Condon C, Watkins SC, Celluzzi CM, et al. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122-8.
24. Irvine KR, Rao JB, Rosenberg SA, et al. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 1996;156:238-45.
25. Fong TC, Sauter SL, Ibanez CE, et al. The use and development of retroviral vectors to deliver cytokine genes for cancer therapy. Crit Rev Ther Drug Carrier Syst 2000;17:1-60.
26. Arthur JF, Butterfield LH, Roth MD, et al. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 1997;4:17-25.
27. - dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2000;165:3584-91.
28. Van Tendeloo VF, Snoeck HW, Lardon F, et al. Nonviral transfection of distinct types of human dendritic cells: High-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells. Gene Ther 1998;5:700-7.
29. Van Tendeloo VF, Ponsaerts P, Lardon F, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001;98:49-56.
30. Heiser A, Dahm P, Yancey DR, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 2000;164:5508-14.
31. Boczkowski D, Nair SK, Snyder D, et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-72.
32. Alijagic S, Moller P, Artuc M, et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 1995;25:3100-7.
33. Strobel I, Berchtold S, Gotze A, et al. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther 2000;7:2028-35.
34. Weissman D, Ni H, Scales D, et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol 2000;165:4710-7.
35. Butterfield LH, Jilani SM, Chakraborty NG, et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol 1998;161:5607-13.
36. Reeves ME, Royal RE, Lam JS, et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996;56:5672-7.
37. + cells. Gene Ther 1998;5:465-72.
38. Dietz AB, Vuk-Pavlovic S. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 1998;91:392-8.
39. + cells. Hum Gene Ther 1999;10:175-87.
40. ++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 1998;91:431-40.
41. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-3.
42. Tillman BW, de Gruijl TD, Luykx-de Bakker SA, et al. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol 1999;162:6378-83.
43. Wickham TJ, Mathias P, Cheresh DA, et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-19.
44. Rea D, Schagen FH, Hoeben RC, et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset, J Virol 1999;73:10245-53.
45. + T cells in patients with melanoma. J Immunol 2000;164:3402-12.
46. Diao J, Smythe JA, Smyth C, et al. Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther 1999;6:845-53.
47. Chen P, Kovesdi I, Bruder JT, Effective repeat administration with adenovirus vectors to the muscle. Gene Ther 2000;7:587-95.
48. Chirmule N, Propert K, Magosin S, et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 1999;6:1574-83.
49. Shean MK, Baskin G, Sullivan D, et al. Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates. Hum Gene Ther 2000;11:1047-55.
50. Salio M, Cella M, Suter M, et al. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999;29:3245-53.
51. Fugier-Vivier I, Servet-Delprat C, Rivailler P, et al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186:813-23.
52. Engelmayer J, Larsson M, Subklewe M, et al. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J Immunol 1999;163:6762-8.